262 related articles for article (PubMed ID: 8992641)
41. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma.
Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP
Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
[TBL] [Abstract][Full Text] [Related]
43. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
[TBL] [Abstract][Full Text] [Related]
44. Preoperative chemoradiotherapy in cancer of the thoracic esophagus.
Terrosu G; Cedolini C; Bresadola V; Baccarani U; Uzzau A; Signor M; Fongione S; Buffoli A; Iop A; Vigevani E; Sacco C; Cartei G; Bresadola F
Dis Esophagus; 2003; 16(1):9-16. PubMed ID: 12581248
[TBL] [Abstract][Full Text] [Related]
45. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
46. Survival effect of neoadjuvant radiotherapy before esophagectomy for patients with esophageal cancer: a surveillance, epidemiology, and end-results study.
Schwer AL; Ballonoff A; McCammon R; Rusthoven K; D'Agostino RB; Schefter TE
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):449-55. PubMed ID: 18538500
[TBL] [Abstract][Full Text] [Related]
47. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
Chang DT; Chapman C; Shen J; Su Z; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
[TBL] [Abstract][Full Text] [Related]
48. [Neoadjuvant therapy of adenocarcinomas of the upper gastrointestinal tract. Status of radiotherapy].
Semrau R; Vallböhmer D; Hölscher AH; Müller RP
Chirurg; 2009 Nov; 80(11):1035-41. PubMed ID: 19820906
[TBL] [Abstract][Full Text] [Related]
49. Results of curative therapy for esophageal cancer in a community training hospital.
Averbach A; Akbarov A; Sidel T; Mech K; Parandian B; Waterfield W; Poussin-Rosillo H; Chang D; Sardi A
Int Surg; 2002; 87(1):31-7. PubMed ID: 12144187
[TBL] [Abstract][Full Text] [Related]
50. [Preoperative radiochemotherapy of esophageal carcinoma. Light at the end of the tunnel?].
Hölscher AH; Metzger R; Schneider PM
Zentralbl Chir; 2000; 125(4):319-25. PubMed ID: 10829311
[TBL] [Abstract][Full Text] [Related]
51. Neoadjuvant therapy for oesophageal cancer.
Mathew G; Jamieson GG
Br J Surg; 1997 Sep; 84(9):1185-7. PubMed ID: 9313692
[No Abstract] [Full Text] [Related]
52. [Esophageal carcinoma: guidelines in surgical therapy].
Kremer B; Marxsen J; Grimm H; Stoffregen C; Schmid A; Henne-Bruns D
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():284-9. PubMed ID: 9931626
[TBL] [Abstract][Full Text] [Related]
53. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
[TBL] [Abstract][Full Text] [Related]
54. [Radiotherapy of esophageal cancer in combination with chemotherapy].
Jinnouchi S; Koga K; Nishikawa K; Kihara Y; Kusuhara T; Watanabe K
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 Nov; 43(11):1278-83. PubMed ID: 6672755
[No Abstract] [Full Text] [Related]
55. Postoperative radiotherapy after esophagectomy: ripe for a randomized trial.
Jiwnani S; Karimundackal G; Pramesh CS; Laskar SG
Ann Thorac Surg; 2011 May; 91(5):1652. PubMed ID: 21524496
[No Abstract] [Full Text] [Related]
56. [Principles of neoadjuvant therapy].
Lordick F
Chirurg; 2009 Nov; 80(11):1000-5. PubMed ID: 19812908
[TBL] [Abstract][Full Text] [Related]
57. [Radiotherapy of esophageal carcinoma: analysis of annual cases in multi-institutes].
Hishikawa Y; Miura T; Tanaka S; Kamikonya N; Abe M; Takahashi M; Hiraoka M; Nishimura Y; Inoue T; Chatani M
Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1203-10. PubMed ID: 3430014
[No Abstract] [Full Text] [Related]
58. Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis.
Bollschweiler E; Metzger R; Drebber U; Baldus S; Vallböhmer D; Kocher M; Hölscher AH
Ann Oncol; 2009 Feb; 20(2):231-8. PubMed ID: 18836090
[TBL] [Abstract][Full Text] [Related]
59. Downstaging of esophageal cancer after preoperative radiation and chemotherapy.
Vogel SB; Mendenhall WM; Sombeck MD; Marsh R; Woodward ER
Ann Surg; 1995 Jun; 221(6):685-93; discussion 693-5. PubMed ID: 7794073
[TBL] [Abstract][Full Text] [Related]
60. Current concepts and future potential in neoadjuvant chemotherapy for esophageal cancer.
Blum Murphy MA; Elimova E; Ajani JA
Expert Rev Gastroenterol Hepatol; 2016; 10(3):383-92. PubMed ID: 26560689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
